NDC 10157-9539

Blistex European Formula

Lanolin, Octinoxate, And Oxybenzone

Blistex European Formula is a Topical Paste in the Human Otc Drug category. It is labeled and distributed by Blistex Inc.. The primary component is Lanolin; Octinoxate; Oxybenzone.

• Product ID: 10157-9539_374e1e4e-e5c2-4089-a86c-a86ed39d67c9
• NDC: 10157-9539
• Product Type: Human Otc Drug
• Proprietary Name: Blistex European Formula
• Generic Name: Lanolin, Octinoxate, And Oxybenzone
• Dosage Form: Paste
• Route of Administration: TOPICAL
• Marketing Start Date: 2011-07-01
• Marketing Category: OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL
• Application Number: part352
• Labeler Name: Blistex Inc.
• Substance Name: LANOLIN; OCTINOXATE; OXYBENZONE
• Active Ingredient Strength: 13 g/100g; g/100g; g/100g
• NDC Exclude Flag: E
• Listing Certified Through: 2017-12-31

Packaging

NDC 10157-9539-1

1 JAR in 1 BLISTER PACK (10157-9539-1) > 7 g in 1 JAR

• Marketing Start Date: 2011-07-01
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 10157-9539-1 [10157953901]

Blistex European Formula PASTE

• Marketing Category: OTC monograph final
• Application Number: part352
• Product Type: HUMAN OTC DRUG
• Marketing Start Date: 2011-07-01
• Inactivation Date: 2019-11-13

Drug Details

Active Ingredients

Ingredient	Strength
LANOLIN	13 g/100g

OpenFDA Data

• SPL SET ID: 197a2d5b-cd4b-431e-940b-f76684db7451
• Manufacturer:
  • Blistex Inc.
• UNII:
  • 95OOS7VE0Y
  • 4Y5P7MUD51
  • 7EV65EAW6H
• UPC Code:
  • 0041388002804